Literature DB >> 11462012

Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities.

F Rodriguez1, M K Slifka, S Harkins, J L Whitton.   

Abstract

Subdominant CD8(+) T-cell responses contribute to control of several viral infections and to vaccine-induced immunity. Here, using the lymphocytic choriomeningitis virus model, we demonstrate that subdominant epitopes can be more reliably identified by DNA immunization than by other methods, permitting the identification, in the virus nucleoprotein, of two overlapping subdominant epitopes: one presented by L(d) and the other presented by K(d). This subdominant sequence confers immunity as effective as that induced by the dominant epitope, against which >90% of the antiviral CD8(+) T cells are normally directed. We compare the kinetics of the dominant and subdominant responses after vaccination with those following subsequent viral infection. The dominant CD8(+) response expands more rapidly than the subdominant responses, but after virus infection is cleared, mice which had been immunized with the "dominant" vaccine have a pool of memory T cells focused almost entirely upon the dominant epitope. In contrast, after virus infection, mice which had been immunized with the "subdominant" vaccine retain both dominant and subdominant memory cells. During the acute phase of the immune response, the acquisition of cytokine responsiveness by subdominant CD8(+) T cells precedes their development of lytic activity. Furthermore, in both dominant and subdominant populations, lytic activity declines more rapidly than cytokine responsiveness. Thus, the lysis(low)-cytokine(competent) phenotype associated with most memory CD8(+) T cells appears to develop soon after antigen clearance. Finally, lytic activity differs among CD8(+) T-cell populations with different epitope specificities, suggesting that vaccines can be designed to selectively induce CD8(+) T cells with distinct functional attributes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462012      PMCID: PMC114975          DOI: 10.1128/JVI.75.16.7399-7409.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells.

Authors:  M K Slifka; F Rodriguez; J L Whitton
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

2.  Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

Authors:  M K Slifka; J L Whitton
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

3.  Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.

Authors:  L L An; F Rodriguez; S Harkins; J Zhang; J L Whitton
Journal:  Vaccine       Date:  2000-04-14       Impact factor: 3.641

4.  Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection.

Authors:  M F Bachmann; M Barner; A Viola; M Kopf
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

5.  Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.

Authors:  E Barker; K N Bossart; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

6.  Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.

Authors:  R S Newmaster; L M Mylin; T M Fu; S S Tevethia
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

7.  Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination.

Authors:  Y Chen; R G Webster; D L Woodland
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

8.  Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma.

Authors:  S C Hsu; O E Obeid; M Collins; M Iqbal; D Chargelegue; M W Steward
Journal:  Int Immunol       Date:  1998-10       Impact factor: 4.823

9.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.

Authors:  A Gallimore; T Dumrese; H Hengartner; R M Zinkernagel; H G Rammensee
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more
  23 in total

1.  Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.

Authors:  Rafaela Holtappels; Doris Thomas; Jürgen Podlech; Matthias J Reddehase
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 2.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

3.  Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.

Authors:  Sanda Remakus; Daniel Rubio; Xueying Ma; Alessandro Sette; Luis J Sigal
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine.

Authors:  Joshua M Walker; Hans-Peter Raué; Mark K Slifka
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

5.  DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge.

Authors:  Natalia Fernandez-Borges; Alejandro Brun; J Lindsay Whitton; Beatriz Parra; Fayna Diaz-San Segundo; Francisco J Salguero; Juan M Torres; Fernando Rodriguez
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Authors:  Hoyin Mok; Sujin Lee; David W Wright; James E Crowe
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

7.  MHC basis of T cell-dependent heterologous immunity to arenaviruses.

Authors:  Keith A Daniels; Steven D Hatfield; Raymond M Welsh; Michael A Brehm
Journal:  Virology       Date:  2014-08-03       Impact factor: 3.616

8.  Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.

Authors:  Ming Ye; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions.

Authors:  Bailey E Freeman; Christine Meyer; Mark K Slifka
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

10.  Expression library immunization can confer protection against lethal challenge with African swine fever virus.

Authors:  Anna Lacasta; María Ballester; Paula L Monteagudo; Javier M Rodríguez; María L Salas; Francesc Accensi; Sonia Pina-Pedrero; Albert Bensaid; Jordi Argilaguet; Sergio López-Soria; Evelyne Hutet; Marie Frédérique Le Potier; Fernando Rodríguez
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.